Slide 1: 3Q24 - Earnings Presentation
3Q24 - Earnings Presentation November 14, 2024
Slide 2: Disclaimer
Disclaimer Forward-looking statements are exclusively related to the prospects of the business, its operating and financial results, and prospects for growth. These data are merely projections and, as such, based exclusively on our management's expectations for the future of the business and its con
Slide 3: Accelerated growth in Sell-out in 3Q24 and at the beginning of 4Q24
Accelerated growth in Sell-out¹ in 3Q24 and at the beginning of 4Q24 15% 13% 11% 10% 7% 6% 5% 4% 4% 0% -5% -10% 3Q23 4Q23 1Q24 2Q24 3Q24 Oct/2024 YTD: 9% Sell-out Flu, Respiratory, Pain and Fever Sell-out 3 Note: ¹According to IQVIA, in PMB/FMB PPP
Slide 4: 3Q24 ESG Highlights
3Q24 ESG Highlights ▪ 10% increase in the Dow Jones Sustainability Index score ▪ Revision of the Regulations of the Board of Directors and the Advisory Committees 4
Slide 5: 3Q24 Results (R$ million)
3Q24 Results (R$ million) NET REVENUE R$1,915.9 -10.4%1 GROSS MARGIN 59.8%2 -350bps1 MARKETING EXPENSES R$347.1 +5.9%1 SELLING EXPENSES R$249.3 +5.4%1 GENERAL AND ADMINISTRATIVE EXPENSES R$98.3 +10.2%1 EBITDA MARGIN FROM CONTINUING OPERATIONS 29.3%2 -800bps1 NET INCOME FROM CONTINUING OPERATIONS R$3
Slide 6: 3Q24 Cash Flow (R$ million)
3Q24 Cash Flow (R$ million) 738 552 (107) (79) (155) (24) 2,836 2.836 3.467 3.388 2.836 3.233 3.209 3,209 (6,998) (10,206) Gross Cash at Cash Flow PP&E Intangibles 3Q24 Free Financing Cash Interest on Gross Cash at Gross Debt at Net Debt at the the end of From Cash Flow Flow Capital the end of the e
Slide 7: efd
efd harma